Thrombophilias: inherited, acquired and antiphospholipid syndrome, and when to test
- Look-alikes compared
Some people clot more easily because of their genes or another illness. Testing helps only when the result would change what is done.
What it is
A thrombophilia is an inherited or acquired tendency to form clots. The inherited ones are factor V Leiden (factor V that resists switching off by activated protein C), the prothrombin gene variant (too much prothrombin) and deficiencies of the natural anticoagulants antithrombin, protein C and protein S. Acquired ones include antiphospholipid syndrome (APS), cancer, myeloproliferative neoplasms, paroxysmal nocturnal haemoglobinuria (PNH), nephrotic syndrome, oestrogens, pregnancy and HIT. Most inherited thrombophilias raise risk only modestly; antithrombin deficiency and APS are the important exceptions.
The difference in one line
- Factor V Leiden is the commonest inherited thrombophilia in people of European ancestry; its frequency varies with ancestry.
- Antithrombin deficiency carries the highest inherited risk and can make heparin work poorly.
- Protein C deficiency predisposes to warfarin-induced skin necrosis; severe inherited deficiency causes purpura fulminans in newborns.
- APS needs both a clinical event (venous or arterial clot, or pregnancy loss or complications) and an antiphospholipid antibody (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein I) positive on two tests at least 12 weeks apart.
- Testing for MTHFR variants or homocysteine does not help in managing venous clots.
Thrombophilias side by side
| Condition | Mechanism | Test and when it misleads | What it changes |
|---|---|---|---|
| Factor V Leiden | Factor V resists activated protein C (accelerator) | Genetic test; reliable at any time | Rarely the length of treatment; oestrogen advice |
| Prothrombin gene variant | Too much prothrombin (accelerator) | Genetic test; reliable at any time | As for factor V Leiden |
| Antithrombin deficiency | Weak brake on thrombin and Xa | Activity level; falls during a clot and on heparin | Higher risk; heparin may work poorly; pregnancy prophylaxis |
| Protein C or S deficiency | Weak brake on factors V and VIII | Activity levels; fall during a clot, on warfarin, in pregnancy (protein S), in liver disease | Warfarin start with heparin cover; pregnancy plans |
| Antiphospholipid syndrome | Antibodies activate platelets, endothelium and placenta | Lupus anticoagulant is distorted by anticoagulants; repeat at 12 weeks | Warfarin rather than DOACs in high risk; pregnancy treatment |
| Acquired states (cancer, MPN, PNH, nephrotic syndrome) | Tumour factors, abnormal cells, complement, urinary loss of antithrombin | Count, smear, JAK2, flow cytometry for PNH, urine protein | Treat the disease; length and choice of anticoagulant |
In clinical practice
- Think of APS in a young patient with a stroke or clot, recurrent pregnancy loss, low platelets or a long aPTT that does not correct.
- Clots in unusual places (brain, liver, gut veins) point to MPN, PNH, APS or cancer rather than an inherited thrombophilia.
- After a clot provoked by major surgery, testing rarely changes anything: the trigger explains it and treatment stops after the usual course.
- Women with a strong family history of antithrombin deficiency may benefit from testing before oestrogen contraception or pregnancy.
How it is confirmed
- Test only if the result will change management, and after explaining what it can and cannot tell.
- Do protein C, protein S and antithrombin activity after the acute clot and off warfarin; genetic tests can be done any time.
- Lupus anticoagulant: best tested off anticoagulants or with the laboratory told which drug is present; confirm any positive antibody at 12 weeks.
- Unusual-site clot: count, smear, JAK2, flow cytometry for PNH, antiphospholipid antibodies and an age-appropriate cancer search.
Common traps
- Testing protein C, S or antithrombin during an acute clot or on warfarin: it can label a false deficiency for life.
- Diagnosing APS from a single positive antibody: transient antibodies are common after infections.
- Using a DOAC in triple-positive APS: more arterial clots than with warfarin.
- Ordering MTHFR or broad 'thrombophilia panels': they do not change treatment but cause anxiety and wrong labels in relatives.
Test yourself
Think of the answer, then tap the question to see it.
Why should protein C and S not be measured during an acute DVT or on warfarin, while factor V Leiden can be tested any time?
Protein C and S levels fall when consumed by a clot and when warfarin blocks vitamin K; factor V Leiden is a DNA test that drugs and clots do not change.
Why does antithrombin deficiency make heparin less effective?
Heparin works by boosting antithrombin; with little antithrombin there is little for heparin to boost.
A woman has had three early pregnancy losses and her lupus anticoagulant is positive once. Does she have APS?
Not yet: the antibody must be positive again at least 12 weeks later, since transient positives are common.
A man has a hepatic vein thrombosis. Which causes should be looked for before inherited thrombophilia?
Myeloproliferative neoplasm (JAK2), PNH, antiphospholipid syndrome and cancer, which cause clots in unusual sites.
Elsewhere in DurgiPedia
- Hypercoagulable states: inherited and acquired
- Thrombosis and Virchow's triad
- Fibrinolysis and natural anticoagulants
- Thrombosis and bleeding: Virchow's triad and hemostatic defects
- Genomic medicine and pharmacogenomics
Connections
Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.
Sources: Factor V Leiden thrombophilia (MedlinePlus Genetics, US National Library of Medicine, 2023); Prothrombin thrombophilia (MedlinePlus (U.S. National Library of Medicine), 2025); Antiphospholipid syndrome: MedlinePlus Genetics (MedlinePlus Genetics, US National Library of Medicine, 2022); Hereditary antithrombin deficiency: MedlinePlus Genetics (MedlinePlus Genetics (U.S. National Library of Medicine), 2026).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
